As additional target for glioma progression was identified in the GRIA2 transcript which is edited by ADAR2 [71], where less editing at the Q/R site enhances glioblastoma invasion through activation of the Akt pathway [141]. This evidence concerns the gene GRIA2 and glioblastoma.